Aarey Drugs & Pharmaceuticals Limited (BSE: 524412)
Health Care · Pharmaceuticals · IN
Rs104.20
+1.12% today · +31.7% 1Y
Aarey Drugs & Pharmaceuticals Limited (BSE: 524412) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $30.64M.
Over the last twelve months the share price has gained 31.7%, trading between 50.40 and 110.00.
Tweenvest scores Aarey Drugs & Pharmaceuticals Limited across four factors: quality 59/100, value 24/100, growth 8/100. Its strongest factor is quality.
524412 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.64M
- Revenue (TTM)
- $43.86M
- P/E
- 82.05
- EPS
- 1.27
- Dividend yield
- —
- Beta (5Y)
- 1.24
- 52-week high
- Rs110.00
- 52-week low
- Rs50.40
- Avg volume (3M)
- —
- Shares outstanding
- 28.45M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioNxt Solutions Inc.CNSX: BNXT | $31.00M | CA$0.33 | -14.47% |
| Sharp Therapeutics Corp.TSXV: SHRX | $30.85M | CA$— | — |
| Astal Laboratories LimitedBSE: 512600 | $30.84M | Rs68.14 | -2.01% |
| New Green Hemp Inc.OTCPK: NGHI | $30.79M | $— | — |
| Eagle Veterinary Technology Co.,LtdKOSDAQ: A044960 | $29.95M | ₩3,185.00 | +3.41% |
| Sabaa International Company for Pharmaceutical and Chemical IndustryCASE: SIPC | $29.60M | EGP6.20 | +20.86% |
| Kyung Nam Pharm Co.,Ltd.KOSDAQ: A053950 | $29.17M | ₩1,999.00 | +0.15% |
| IGC Pharma, Inc.NYSEAM: IGC | $28.94M | $0.27 | -3.18% |
Figures last refreshed Oct 11, 2026.